Predicting the Need for ICU Admission in COVID-19 Patients Using XGBoost
Source abstract
Abstract
It is important to determine early on which patients require ICU admissions in managing COVID-19 especially when medical resources are limited. Delay in ICU admissions is associated with negative outcomes such as mortality and cost. Therefore, early identification of patients with a high risk of respiratory failure can prevent complications, enhance risk stratification, and improve the outcomes of severely-ill hospitalized patients. In this paper, we develop a model that uses the characteristics and information collected at the time of patients’ admissions and during their early period of hospitalization to accurately predict whether they will need ICU admissions. We use the data explained and organized in a window-based manner by the Sírio-Libanês hospital team (published on Kaggle). Preprocessing is applied, including imputation, cleaning, and feature selection. In the cleaning process, we remove zero-variance, redundant, and/or highly correlated (measured by the Pearson correlation coefficient) features. We use Extreme Gradient Boosting (XGBoost) with early stopping as a predictor in our developed model. We run the experiment in four stages starting from the features of Window 1 in Stage 1 and then incrementally add the features of Windows 2–4 in Stages 2–4 respectively. We achieve AUCs of 0.73, 0.92, 0.95, and 0.97 in those four stages.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: COVID-19 diagnosis using AI · Sepsis Diagnosis and Treatment · Machine Learning in Healthcare
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (29)
Show source-provided references
1. Truncated inception net: COVID-19 outbreak screening using chest X-rays10.1007/s13246-020-00888-x ↗
2. W. H. Organization, Weekly operational update on COVID-19 report, 2020. [Online]. Available: https://www.who.int/publications/m/item/weekly-update-on-covid-19---25-september.
3. Structural vulnerability in the us revealed in three waves of covid-1910.4269/ajtmh.20-0391 ↗
4. CDC, Interim clinical guidance for management of patients with confirmed coronavirus disease (COVID-19), 2020. [Online]. Available: https://stacks.cdc.gov/view/cdc/89980.
5. Covid-19 and immunity in aging populations—A new research agenda10.1056/NEJMp2006761 ↗
6. Demand forecast and optimal planning of intensive care unit (ICU) capacity10.1590/0101-7438.2017.037.02.0229 ↗
7. Current and projected workforce requirements for care of the critically ill and patients with pulmonary disease: Can we meet the requirements of an aging population?10.1001/jama.284.21.2762 ↗
8. Adults hospitalized with pneumonia in the united states: Incidence, epidemiology, and mortality10.1093/cid/cix647 ↗
9. Burden of community-acquired pneumonia in north american adults10.3810/pgm.2010.03.2130 ↗
10. Clinical scoring tools: Which is best to predict clinical response and long-term outcomes?
11. Severity assessment tools to guide ICU admission in community-acquired pneumonia: Systematic review and meta-analysis10.1007/s00134-011-2261-x ↗
12. SMART-COP: A tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia10.1086/589754 ↗
13. A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit10.1007/BF02425150 ↗
14. Late admission to the ICU in patients with community-acquired pneumonia is associated with higher mortality10.1378/chest.09-1547 ↗
15. Validation of the infectious diseases society of america/american thoratic society minor criteria for intensive care unit admission in community-acquired pneumonia patients without major criteria or contraindications to intensive care unit care10.1093/cid/cir463 ↗
16. Validation of the infectious diseases society of america/american thoracic society criteria to predict severe community-acquired pneumonia caused by streptococcus pneumoniae10.1016/j.ajem.2008.07.037 ↗
17. Validation and clinical implications of the IDSA/ATS minor criteria for severe community acquired pneumonia10.1136/thx.2009.113795 ↗
18. Predicting need for intensive care unit admission in adult emphysematous pyelonephritis patients at emergency departments: Comparison of five scoring systems10.1038/s41598-019-52989-7 ↗
19. Performance of machine learning approaches on prediction of esophageal varices for Egyptian chronic hepatitis C patients10.1016/j.imu.2019.100267 ↗
20. Greedy function approximation: A gradient boosting machine10.1214/aos/1013203451 ↗
21. Xgboost: A scalable tree boosting system
22. Defining an optimal cut-point value in roc analysis: An alternative approach10.1155/2017/3762651 ↗
23. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China10.1016/S0140-6736(20)30183-5 ↗
24. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China10.1001/jama.2020.1585 ↗
25. Using IL-2R/lymphocyte for predicting the clinical progression of patients with covid-1910.1111/cei.13450 ↗
26. Covid-19 and chronic diseases: Current knowledge, future steps and the MaCroScopio project
27. Clinical features and outcomes of severe acute respiratory syndrome and predictive factors for acute respiratory distress syndrome10.1016/S1726-4901(09)70124-8 ↗
28. Electrolyte imbalances in patients with severe coronavirus disease 2019 (covid19)10.1177/0004563220922255 ↗
29. D-dimer as a biomarker for disease severity and mortality in covid-19 patients: A case control study10.1186/s40560-020-00466-z ↗